artesunic acid has been researched along with Carcinogenesis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Che, F; Peng, S; Song, Q; Zhu, X | 1 |
Dong, H; Jing, W; Jun, X; Min, M; Runpeng, Z; Shuo, L; Yingru, X | 1 |
Fujii, G; Hamoya, T; Iizumi, Y; Kishimoto, S; Komiya, M; Kondo, T; Matsuzawa, Y; Miki, K; Mutoh, M; Narita, T; Sakai, T; Toshima, J; Wakabayashi, K; Watanabe, K | 1 |
3 other study(ies) available for artesunic acid and Carcinogenesis
Article | Year |
---|---|
Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells.
Topics: Antimalarials; Antineoplastic Agents; Artesunate; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Ferroptosis; Glioblastoma; Homeostasis; Humans; Iron; MAP Kinase Signaling System; Molecular Targeted Therapy; Reactive Oxygen Species | 2022 |
Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma.
Topics: Animals; Apoptosis; Artesunate; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Liver Neoplasms; MAP Kinase Signaling System; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-akt; Sorafenib; TOR Serine-Threonine Kinases | 2019 |
Artesunate inhibits intestinal tumorigenesis through inhibiting wnt signaling.
Topics: Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Animals; Artesunate; Carcinogenesis; Cell Line, Tumor; Cell Nucleus; Disease Models, Animal; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hepatocyte Nuclear Factor 1-alpha; Humans; Intestinal Mucosa; Male; Mice; Mice, Transgenic; Mutation; Promoter Regions, Genetic; ran GTP-Binding Protein; T Cell Transcription Factor 1; Transcriptional Activation; Wnt Signaling Pathway | 2021 |